Tunde Babalola is Senior Vice President, Technical Operations at Fate Therapeutics, overseeing all GxP operations, process development, quality and compliance activities. Dr. Babalola is an accomplished leader with more than 15 years of diverse experience spanning cell therapy, biologics, small molecules, combination products and medical implants. Before joining Fate, Dr. Babalola worked at Kite, A Gilead Company, leading quality control and quality assurance site organizations at Kite’s Clinical and Commercial facilities for Yescarta® and Tecartus®. Prior to that she held multiple roles of increasing responsibilities at Bristol Myers Squibb both at their corporate headquarters and at their manufacturing sites in Puerto Rico, including leading the successful US launches of Orencia® SC and Nulogix®, and as quality lead for Yervoy® and Eliquis® at critical commercial manufacturing and packaging facilities for global supply. Dr. Babalola received a B.Sc. in Biomedical Engineering with a concentration in Mechanical Engineering from the University of Rochester and a Ph.D. in Biomedical Engineering from Cornell University.
